ArticleScientific reports2025
Ink based graphene integration into commercial contact lenses.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Iron-oxide nanoparticle-integrated soft contact lenses: optical optimization, catalytic functionality, and biocompatibility.Frontiers in medical technology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introducing multiple functionalities to contact lenses (CLs) are achieved by additives such as nanomaterials, pigments, and dyes. CLs with graphene have been used in electromagnetic interference (EMI) shielding, drug delivery and sensing. Generally, CVD graphene or graphene nanocomposites are used during the manufacturing stage of CLs. In this work, we incorporate graphene into commercial CLs through three post processing techniques: the breath in - breath out (BIBO) technique, immersion of CLs in graphene ink, and 3D printing of graphene hydrogel composite. Graphene ink was used as the aqueous solution in BIBO cycles. The BIBO cycles were repeated to obtain the necessary attachment without losing transparency. In the immersion technique, immersion time controlled the concentration of graphene. In the third method, graphene ink was dispersed in hydroxyethyl methacrylate (HEMA) resin to 3D print patterns onto the CLs. Scanning Electron Microscopy (SEM) was used to observe graphene dispersion within CLs. The UV-Vis spectroscopy of the CLs indicated steady absorption throughout the visible region as a tinting additive, suggesting uses such as broad-spectrum absorbers. These methods could be used to quickly synthesize large amount of functionalized CLs for different applications. The lenses exhibited both anti-bacterial and exceptional biocompatibility properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.